BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2567045)

  • 21. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunology in AIDS in 1990.
    Sela M
    AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
    Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunology and the elusive AIDS vaccine.
    Virgin HW; Walker BD
    Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
    Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK
    Cell; 2001 Sep; 106(5):539-49. PubMed ID: 11551502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic T lymphocytes against HIV.
    Walker BD; Plata F
    AIDS; 1990 Mar; 4(3):177-84. PubMed ID: 1693514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunology of infection with the human immunodeficiency virus.
    Seligmann M
    Recenti Prog Med; 1988; 79(7-8):330-7. PubMed ID: 2904683
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenic structures recognized by T cells: towards the rational design of an AIDS vaccine.
    Cease KB; Berzofsky JA
    AIDS; 1988; 2 Suppl 1():S95-101. PubMed ID: 3147685
    [No Abstract]   [Full Text] [Related]  

  • 30. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for a vaccine against HIV.
    Ada G
    Nature; 1989 Jun; 339(6223):331-2. PubMed ID: 2725655
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I trial of potential AIDS vaccine commences.
    Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV-peplotion vaccine. A novel approach to vaccination against AIDS by transepithelial transport of viral peptides and antigens to Langerhans cells for induction of cytolytic T cells by HLA class I and CD1 molecules for long term protection.
    Becker Y
    Adv Exp Med Biol; 1996; 397():97-104. PubMed ID: 8718588
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 24th forum in immunology. HIV-specific cytotoxic T lymphocytes.
    Res Immunol; 1989 Jan; 140(1):89-124. PubMed ID: 2786232
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS response.
    Nature; 1991 Dec; 354(6353):439-40. PubMed ID: 1684222
    [No Abstract]   [Full Text] [Related]  

  • 37. A winding road towards an HIV vaccine.
    Rowland-Jones S
    Eur J Immunol; 2008 Jan; 38(1):13-4. PubMed ID: 18286707
    [No Abstract]   [Full Text] [Related]  

  • 38. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 39. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
    Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH
    Ann Intern Med; 1989 Mar; 110(5):373-85. PubMed ID: 2464961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.